Understanding the Different Forms of VLCADD

While every child with VLCADD is unique, doctors generally group the condition into three main clinical forms or “phenotypes.” These categories are based on when symptoms first appear and which parts of the body are most affected.

It is important to remember that newborn screening identifies many affected infants—across the spectrum of severity—but it may occasionally miss some individuals with very mild or later-onset forms ^[1]. A normal newborn screen does not completely exclude VLCADD if concerning symptoms arise later in life.

The Three Clinical Forms

The timing and nature of symptoms often depend on how much working enzyme a child has left. These labels are useful frameworks, but they are not rigid boxes; a child’s experience may blend these categories.

1. Severe Infantile Form: This is the most serious presentation and typically appears in the first few days or months of life ^[2]. It is often characterized by cardiomyopathy (a weakening of the heart muscle) and an enlarged heart ^[3]. Babies with this form are at high risk for heart rhythm problems and severe low blood sugar. Because this form can progress very quickly, these babies require intensive monitoring and a strict treatment plan ^[1][4].
2. Childhood Form (Hepatic Form): This form usually appears in early childhood, often triggered by a common illness (like a stomach bug) or a long period without eating ^[4]. The main concern is hypoketotic hypoglycemia—a dangerous drop in blood sugar without the usual backup energy sources (ketones) the body typically produces ^[5]. It may also involve hepatomegaly (an enlarged liver). Between these episodes, children with this form often seem perfectly healthy ^[1].
3. Adolescent/Adult Form (Myopathic Form): This is generally considered a milder form that may not cause symptoms until later in life ^[6]. It primarily affects the muscles rather than the heart or liver. Symptoms include muscle pain (myalgia), weakness, and rhabdomyolysis—a condition where muscle tissue breaks down and can potentially damage the kidneys ^[7]. These episodes are usually triggered by intense exercise, fasting, or cold exposure ^[3].

Interpreting Severity and Functional Tests

One of the most confusing parts of a VLCADD diagnosis is that your baby’s genes (genotype) do not always perfectly predict how they will feel (phenotype) ^[4].

To get a clearer picture, doctors sometimes use “functional” tests, specifically the LC-FAO flux, which measures the cells’ fat-burning capacity. Research has identified certain associations that may assist in interpretation:

• Lower Flux Values: In some studies, a flux below 10% has been highly associated with the more severe infantile form, requiring strict dietary treatment and very close monitoring ^[1][3].
• Higher Flux Values: Values above 10% are often associated with the childhood or adult forms, though outcomes remain variable ^[1][8].

It is crucial to understand that these numbers are research-based associations used to guide care, not absolute guarantees. A residual flux percentage cannot reliably predict an individual child’s exact clinical course, nor does a higher number make future symptoms or exercise-related muscle pain impossible.

The Role of Newborn Screening

The goal of newborn screening is to find children with VLCADD before they ever get sick. For many children, early detection is life-changing because it allows parents to prevent low blood sugar and catabolism before it happens ^[1][4].

However, for babies with the most severe infantile form, screening is just the beginning. While it alerts doctors to start treatment early, these babies still carry a high risk for heart and energy problems. This is why close coordination with a metabolic specialist is absolutely required to keep your child safe, regardless of their screening results ^[1][8].